investment analyst coverage
BTIG Initiates Coverage of Cue Health With Buy Rating
The investment bank said the company is well positioned to take shares from reference labs and other point-of-care testing companies.
William Blair, Cowen Initiate Coverage of Sera Prognostics With Outperform Rating
Both banks highlighted the market potential of Sera's preterm birth risk test and pipeline products but warned of the company's early stage.
BTIG Initiates Coverage of DermTech With Buy Rating
The investment bank said DermTech's pigmented lesion assay for the early detection of melanoma is well positioned in an estimated $3 billion-plus market.
Investment Banks Initiate Coverage of Talis Biomedical With Bullish Outlooks
Talis, which went public last month, develops point-of-care infectious disease tests based on its flagship Talis One sample-to-answer platform.
Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings
Danaher’s guidance of double-digit top-line growth for 2021 provides upside opportunities that depend mostly on the success of vaccine rollouts, Barclays said.
Nov 30, 2020
BTIG Initiates Coverage of Oncocyte With Buy Rating
Nov 23, 2020
Three Investment Banks Initiate Coverage of Biodesix
Oct 23, 2020
BTIG Initiates Coverage of Progenity With Buy Rating
Oct 14, 2020
JP Morgan Rates Invitae Neutral
Jun 26, 2020
BTIG Initiates Coverage of CareDx With Buy Rating
May 29, 2020
BTIG Initiates Coverage of Fulgent Genetics
May 18, 2020